LTD

FDA Rescinds Rule that Applied Med Device Rules to Lab-Developed Tests

The U.S. Food and Drug Administration (FDA) has now rescinded 2024 rules that required laboratory-developed tests (LTDs) to comply with the agency’s pre-marketing authorization requirements applicable to medical devices.

Digital Sponsors

Become a Sponsor

What's New

Preparing for Compliance Testing: A Step‑by‑Step Guide for Engineers in Product Development and EMC/Safety Certification

U.S. Senate to Consider Bill to Require Cyber Review of Chinese-Made Medical Devices

FCC Plans Auction of Prime Mid-Band Spectrum

EMC Bench Notes: Troubleshooting with a Nearby Antenna

FDA Updates Medical Device Shortages List

- From Our Sponsors -